SIEMENS HEALTHINEERS AG (SHL.DE) Fundamental Analysis & Valuation

FRA:SHL • DE000SHL1006

Current stock price

38.47 EUR
+0.13 (+0.34%)
Last:

This SHL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SHL.DE Profitability Analysis

1.1 Basic Checks

  • SHL had positive earnings in the past year.
  • In the past year SHL had a positive cash flow from operations.
  • In the past 5 years SHL has always been profitable.
  • In the past 5 years SHL always reported a positive cash flow from operatings.
SHL.DE Yearly Net Income VS EBIT VS OCF VS FCFSHL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • The Return On Assets of SHL (4.79%) is better than 66.67% of its industry peers.
  • SHL has a Return On Equity of 11.50%. This is in the better half of the industry: SHL outperforms 74.60% of its industry peers.
  • SHL's Return On Invested Capital of 7.88% is fine compared to the rest of the industry. SHL outperforms 66.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 10.15%.
  • The last Return On Invested Capital (7.88%) for SHL is above the 3 year average (6.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.79%
ROE 11.5%
ROIC 7.88%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
SHL.DE Yearly ROA, ROE, ROICSHL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • The Profit Margin of SHL (9.10%) is better than 68.25% of its industry peers.
  • SHL's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 13.49%, SHL is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
  • SHL's Operating Margin has been stable in the last couple of years.
  • SHL's Gross Margin of 38.44% is on the low side compared to the rest of the industry. SHL is outperformed by 82.54% of its industry peers.
  • SHL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.49%
PM (TTM) 9.1%
GM 38.44%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
SHL.DE Yearly Profit, Operating, Gross MarginsSHL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. SHL.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
  • Compared to 1 year ago, SHL has less shares outstanding
  • Compared to 5 years ago, SHL has more shares outstanding
  • The debt/assets ratio for SHL has been reduced compared to a year ago.
SHL.DE Yearly Shares OutstandingSHL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SHL.DE Yearly Total Debt VS Total AssetsSHL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 1.90 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • SHL's Altman-Z score of 1.90 is on the low side compared to the rest of the industry. SHL is outperformed by 63.49% of its industry peers.
  • The Debt to FCF ratio of SHL is 6.56, which is on the high side as it means it would take SHL, 6.56 years of fcf income to pay off all of its debts.
  • SHL has a Debt to FCF ratio of 6.56. This is comparable to the rest of the industry: SHL outperforms 52.38% of its industry peers.
  • A Debt/Equity ratio of 0.53 indicates that SHL is somewhat dependend on debt financing.
  • SHL's Debt to Equity ratio of 0.53 is on the low side compared to the rest of the industry. SHL is outperformed by 60.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.56
Altman-Z 1.9
ROIC/WACC1.26
WACC6.27%
SHL.DE Yearly LT Debt VS Equity VS FCFSHL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • SHL has a Current Ratio of 1.04. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.04, SHL is doing worse than 76.19% of the companies in the same industry.
  • SHL has a Quick Ratio of 1.04. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.72, SHL is doing worse than 73.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.72
SHL.DE Yearly Current Assets VS Current LiabilitesSHL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

4

3. SHL.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.33% over the past year.
  • The Earnings Per Share has been growing by 11.29% on average over the past years. This is quite good.
  • SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 2.76%.
  • SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.08% yearly.
EPS 1Y (TTM)1.33%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%-21.57%
Revenue 1Y (TTM)2.76%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-1.46%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.69% on average over the next years. This is quite good.
  • Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 5.34% on average per year.
EPS Next Y-2.64%
EPS Next 2Y5.26%
EPS Next 3Y7.63%
EPS Next 5Y8.69%
Revenue Next Year1.77%
Revenue Next 2Y3.91%
Revenue Next 3Y4.63%
Revenue Next 5Y5.34%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SHL.DE Yearly Revenue VS EstimatesSHL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
SHL.DE Yearly EPS VS EstimatesSHL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

5

4. SHL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.87, the valuation of SHL can be described as correct.
  • Based on the Price/Earnings ratio, SHL is valued cheaper than 85.71% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.38, SHL is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 14.53 indicates a correct valuation of SHL.
  • SHL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SHL is cheaper than 77.78% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SHL to the average of the S&P500 Index (38.20), we can say SHL is valued rather cheaply.
Industry RankSector Rank
PE 16.87
Fwd PE 14.53
SHL.DE Price Earnings VS Forward Price EarningsSHL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 61.90% of the companies listed in the same industry.
  • SHL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SHL is cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.42
EV/EBITDA 12.38
SHL.DE Per share dataSHL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.49
EPS Next 2Y5.26%
EPS Next 3Y7.63%

6

5. SHL.DE Dividend Analysis

5.1 Amount

  • SHL has a Yearly Dividend Yield of 2.68%. Purely for dividend investing, there may be better candidates out there.
  • SHL's Dividend Yield is rather good when compared to the industry average which is at 1.23. SHL pays more dividend than 82.54% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, SHL pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.68%

5.2 History

  • The dividend of SHL has a limited annual growth rate of 4.38%.
Dividend Growth(5Y)4.38%
Div Incr Years1
Div Non Decr Years7
SHL.DE Yearly Dividends per shareSHL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 50.31% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
  • SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP50.31%
EPS Next 2Y5.26%
EPS Next 3Y7.63%
SHL.DE Yearly Income VS Free CF VS DividendSHL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
SHL.DE Dividend Payout.SHL.DE Dividend Payout, showing the Payout Ratio.SHL.DE Dividend Payout.PayoutRetained Earnings

SHL.DE Fundamentals: All Metrics, Ratios and Statistics

SIEMENS HEALTHINEERS AG

FRA:SHL (4/16/2026, 2:02:58 PM)

38.47

+0.13 (+0.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-05
Earnings (Next)05-07
Inst Owners13.8%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap43.39B
Revenue(TTM)23.30B
Net Income(TTM)2.12B
Analysts79.29
Price Target54.55 (41.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.68%
Yearly Dividend0.95
Dividend Growth(5Y)4.38%
DP50.31%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.86%
Min EPS beat(2)-13.74%
Max EPS beat(2)-3.98%
EPS beat(4)1
Avg EPS beat(4)-1.6%
Min EPS beat(4)-13.74%
Max EPS beat(4)13.36%
EPS beat(8)4
Avg EPS beat(8)1.31%
EPS beat(12)6
Avg EPS beat(12)0.88%
EPS beat(16)9
Avg EPS beat(16)1.56%
Revenue beat(2)1
Avg Revenue beat(2)-1.97%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)0.15%
Revenue beat(4)2
Avg Revenue beat(4)-1.11%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)0.27%
Revenue beat(8)3
Avg Revenue beat(8)-1.06%
Revenue beat(12)4
Avg Revenue beat(12)-0.67%
Revenue beat(16)7
Avg Revenue beat(16)-0.39%
PT rev (1m)-0.88%
PT rev (3m)-3.63%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)-12.1%
EPS NY rev (1m)0.75%
EPS NY rev (3m)-2.33%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-2.36%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-1.04%
Valuation
Industry RankSector Rank
PE 16.87
Fwd PE 14.53
P/S 1.86
P/FCF 19.42
P/OCF 14.26
P/B 2.35
P/tB N/A
EV/EBITDA 12.38
EPS(TTM)2.28
EY5.93%
EPS(NY)2.65
Fwd EY6.88%
FCF(TTM)1.98
FCFY5.15%
OCF(TTM)2.7
OCFY7.01%
SpS20.65
BVpS16.34
TBVpS-4.52
PEG (NY)N/A
PEG (5Y)1.49
Graham Number28.9504 (-24.75%)
Profitability
Industry RankSector Rank
ROA 4.79%
ROE 11.5%
ROCE 10.26%
ROIC 7.88%
ROICexc 8.62%
ROICexgc 53.82%
OM 13.49%
PM (TTM) 9.1%
GM 38.44%
FCFM 9.59%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.75%
ROICexc(5y)6.62%
ROICexgc(3y)33.94%
ROICexgc(5y)34.43%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y11.98%
ROICexgc growth 5Y11.06%
ROICexc growth 3Y9.08%
ROICexc growth 5Y-1.26%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score7
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 6.56
Debt/EBITDA 2.22
Cap/Depr 62.76%
Cap/Sales 3.47%
Interest Coverage 7.31
Cash Conversion 68.7%
Profit Quality 105.47%
Current Ratio 1.04
Quick Ratio 0.72
Altman-Z 1.9
F-Score7
WACC6.27%
ROIC/WACC1.26
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)1.33%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%-21.57%
EPS Next Y-2.64%
EPS Next 2Y5.26%
EPS Next 3Y7.63%
EPS Next 5Y8.69%
Revenue 1Y (TTM)2.76%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-1.46%
Revenue Next Year1.77%
Revenue Next 2Y3.91%
Revenue Next 3Y4.63%
Revenue Next 5Y5.34%
EBIT growth 1Y7.86%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year31.85%
EBIT Next 3Y17.07%
EBIT Next 5Y13.29%
FCF growth 1Y40.04%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y28.66%
OCF growth 3Y12.15%
OCF growth 5Y12.87%

SIEMENS HEALTHINEERS AG / SHL.DE Fundamental Analysis FAQ

What is the fundamental rating for SHL stock?

ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.


Can you provide the valuation status for SIEMENS HEALTHINEERS AG?

ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.


What is the profitability of SHL stock?

SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.


What is the earnings growth outlook for SIEMENS HEALTHINEERS AG?

The Earnings per Share (EPS) of SIEMENS HEALTHINEERS AG (SHL.DE) is expected to decline by -2.64% in the next year.


Is the dividend of SIEMENS HEALTHINEERS AG sustainable?

The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 50.31%.